Recombinant avian infectious coryza vaccine and process for preparing same
Abstract
A recombinant avian infectious coryza vaccine and a process for preparing the same are provided. A process for preparing a recombinant avian infectious coryza vaccine which comprises step of constructing E. coli that may produce as an inclusion body a fusion peptide consisting of peptides derived from outer-membrane protein of Avibacterium paragarinarum serotype A and serotype C, step of culturing said E. coli and colleting and purifying inclusion body from culture, and step of preparing a preparation comprising said purified inclusion body, and an avian infectious coryza vaccine comprising as an active ingredient the fusion peptide. A linker sequence may be inserted between the respective peptides comprising the fusion peptide. For the peptide derived from the serotypes A and C, an amino acid sequence region of Region 2 or its vicinity responsible for protection from infection may be used.
Claims
exact text as granted — not AI-modified1 - 19 . (canceled)
20 . A recombinant avian infectious coryza vaccine comprising as an active ingredient a peptide consisting of a sequence comprising the amino acid sequence shown by SEQ ID NO: 35, said sequence being within the amino acid sequence shown by SEQ ID NO: 1 with addition of 1 to 200 amino acid residues at the N-terminal and/or C-terminal thereof.
21 . The vaccine of claim 20 wherein said vaccine comprises as an active ingredient a peptide consisting of the amino acid sequence shown by SEQ ID NO: 1.
22 - 23 . (canceled)
24 . The vaccine of claim 21 or 23 wherein said peptide comprises an amino acid sequence where one or several amino acids are deleted, added or replaced.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.